ACB
Aurora Cannabis Inc.
$3.46
Distressed or Transitioning
75%
Current EPS × Depressed Multiple
Strong
·
Conviction
Overvalued
Trading 165.3% above fair value
You pay
$3.46
Bear
$0.87
Fair
$1.30
Bull
$1.83
Bear
$0.87
-74.9%
EPS continues to decline, 5x multiple
Fair
$1.30
-62.3%
Current EPS stabilizes, 8x multiple
Bull
$1.83
-47.2%
Credible recovery, multiple re-rates to 10x
Key Value Driver
Whether the core business model is intact or structurally impaired
Implied Market Multiple
167.6x
Summary
Our base-case estimate uses Current EPS × Depressed Multiple. We then blend that result with the average analyst price target of $5.92 from 14 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $1.30 per share.
Warnings
Don't assume past cash flow levels will return — the company's troubles may have permanently reduced its ability to generate profits.
A stock can look cheap on paper and still lose half its value if the underlying business is permanently damaged.
The wide range between our best and worst cases is intentional — pretending to know a precise value for a troubled company would be misleading.
Wall Street's average price target is $5.92 (from 14 analysts). Our estimate is 97% below the consensus -- consider that gap carefully.
Financial statements were converted from CAD into USD using USDCAD at 0.7245 USD per CAD.
Key Risks
- Bullish DCF projections are fundamentally unknowable for distressed companies
- M&A speculation can floor the stock above intrinsic value temporarily
- Management credibility is a key input — new CEO expands the bull case